Taken as a whole, studies suggest that MDD is associated with all the cardinal features of an inflammatory response including increased proinflammatory cytokines and their receptors and increased acute phase reactants, chemokines, and soluble adhesion molecules in peripheral blood (Lieb et al, 1983; Calabrese et al, 1986; Sluzewska et al, 1996; Song et al, 1998; Howren et al, 2009; Dowlati et al, 2010; Liu et al, 2012b; Valkanova et al, 2013; Black and Miller, 2015; Haapakoski et al, 2015; Eyre et al, 2016; Goldsmith et al, 2016b; van Dooren et al, 2016) .
This has been shown in studies examining the acute behavioral and CNS responses to a single exposure to endotoxin or typhoid vaccine and even more convincingly by the many studies examining the biological and behavioral effects of chronic immune activation secondary to treatment with the cytokine IFN-α for either cancer or hepatitis C virus infection (Capuron et al, 2002 (Capuron et al, , 2003a (Capuron et al, , 2003b (Capuron et al, , 2005 (Capuron et al, , 2007 (Capuron et al, , 2009 Wichers and Maes, 2004; Wichers et al, 2005b Wichers et al, , 2006 Wichers et al, , 2007 Majer et al, 2008; Harrison et al, 2009a Harrison et al, , 2009b Lotrich, 2009; Lotrich et al, 2009; Prather et al, 2009; Raison et al, 2009 Raison et al, , 2010a Raison et al, , 2010b Raison et al, , 2010d Eisenberger et al, 2010a, b; Franzen et al, 2010; Felger et al, 2011 Felger et al, , 2012 .
And while chronic stress is best known to suppress certain aspects of immune function (ie, natural killer cell activity, circulating T-cell subsets; Herbert and Cohen, 1993c) , the types of acute and/ or psychosocial stressors most likely to be associated with immediate risk of wounding and hence infection activate both innate and adaptive immunity (Quan et al, 2001; Bierhaus et al, 2003; Avitsur et al, 2005; Viswanathan et al, 2005; Pace et al, 2006b; Steptoe et al, 2007; Joachim et al, 2008; Bailey et al, 2009; Rosenberger et al, 2009; Mays et al, 2010; Powell et al, 2010) .
A number of viruses have been reported to be restricted by BST2, including retroviruses (alpha-, beta-, delta-, lenti-, and spuma-) (Jouvenet et al., 2009) , arenaviruses (Lassa virus and Machupo virus) (Radoshitzky et al., 2010; Sakuma et al., 2009) , herpesviruses (Kaposi's sarcoma-associated herpesvirus and human simplex virus) (Blondeau et al., 2013; Liu et al., 2015; Mansouri et al., 2009; Zenner et al., 2013) , filoviruses (Ebola virus and Marburg virus) (Jouvenet et al., 2009; Sakuma et al., 2009) , rhabdoviruses (vesicular stomatitis virus) (Weidner et al., 2010) , paramyxoviruses (Nipah virus), orthomyxoviruses (influenza A virus) (Watanabe et al., 2011; Yondola et al., 2011) , and flaviviruses (Dengue virus) (Pan et al., 2012) .
The availability of genotyping data across all CC lines opened the way to analyses of QTLs in a variety of traits, including behavioral and morphological phenotypes (Aylor et al., 2011; Chesler, 2014; Mao et al., 2015; Percival et al., 2016) , homeostatic immune processes (Kelada et al., 2012; Phillippi et al., 2014) , susceptibility to infectious diseases (Durrant et al., 2011; Ferris et al., 2013; Vered et al., 2014; Graham et al., 2015; Gralinski et al., 2015; Lorè et al., 2015) , and liver-related functionalities (Kelada et al., 2012; Svenson et al., 2012; Thaisz et al., 2012) .
Attenuated vectors derived from VSV have been used extensively as experimental vaccine candidates (Daddario-DiCaprio et al., 2006a,b; Egan et al., 2004; Geisbert et al., 2005; Jones et al., 2005; Kahn et al., 2001; Natuk et al., 2006; Palin et al., 2007; Ramsburg et al., 2004; Reuter et al., 2002; Roberts et al., 1999 Roberts et al., , 1998 Roberts et al., , 2004 Rose et al., 2001; Schlereth et al., 2003 Schlereth et al., , 2000 .
Our laboratory is using functional genomics to study a variety of viruses, including HCV, SIV/HIV, Ebola virus, HSV, SARS coronavirus, West Nile virus, and influenza virus (Baas et al., 2006a,b; Baskin et al., 2004; Fredericksen et al., 2004; Geiss et al., 2000 Geiss et al., , 2001 Geiss et al., , 2002 Geiss et al., , 2003 Kash et al., 2004 Kash et al., , 2006a Kobasa et al., 2007; Lederer et al., 2006; Pasieka et al., 2006; Smith et al., 2003a Smith et al., ,b, 2006 Thomas et al., 2006; Walters et al., 2006 Walters et al., , 2006a .
Causes of CD4 + cell loss include decreased production secondary to bone marrow or thymic infection, lysis of infected cells induced by FIV itself (cytopathic effects), destruction of virus-infected cells by the immune system, or death by apoptosis (cell death that follows receipt of a membrane signal initiating a series of programmed intracellular events) (Bishop et al., 1993; Ohno et al., 1993 Ohno et al., , 1994 Johnson et al., 1996; Guiot et al., 1997a,b; Mizuno et al., 1997; Mortola et al., 1998a,b; Piedimonte et al., 1999; Mizuno et al., 2001 Mizuno et al., , 2003b Tompkins et al., 2002) .
